The JAK2V617F mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burden

Lai Yee Orbell, Nouf Abutheraa, Andrew S. Duncombe, Mary Frances McMullin, Ruben Mesa, Charlene McShane, Glen James, Lesley Anderson* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The JAK2V617F mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burden'. Together they form a unique fingerprint.

Medicine & Life Sciences